MARKET

SVA

SVA

Sinovac Biotech Ltd
NASDAQ
6.47
0.00
0.00%
Suspension 04:00 09/25 EDT
OPEN
6.47
PREV CLOSE
6.47
HIGH
6.47
LOW
6.47
VOLUME
0
TURNOVER
0
52 WEEK HIGH
6.58
52 WEEK LOW
6.25
MARKET CAP
388.59M
P/E (TTM)
-4.9314
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SVA last week (1222-1226)?
Weekly Report · 22h ago
NASDAQ TRADE HALT CONTINUES <SVA.O> REASON NOT AVAILABLE AT 03:28 AM
Reuters · 3d ago
Weekly Report: what happened at SVA last week (1215-1219)?
Weekly Report · 12/22 10:04
Antigua High Court gives Sinovac Biotech board control until trial
TipRanks · 12/17 12:15
Sinovac Biotech Announces Antigua High Court Makes Interim Order Giving Board Control Of The Company Until Trial Of Disputed 2025 Shareholder Meeting
Benzinga · 12/17 12:05
SINOVAC: ANTIGUA COURT MAKES INTERIM ORDER GIVING BOARD CONTROL OF THE COMPANY UNTIL THE TRIAL OF THE DISPUTED 2025 SHAREHOLDER MEETING
Reuters · 12/17 12:00
SINOVAC BIOTECH LTD - SSM DISPUTE HEARING SCHEDULED FOR LATE APRIL/ EARLY MAY 2026
Reuters · 12/17 12:00
Weekly Report: what happened at SVA last week (1208-1212)?
Weekly Report · 12/15 10:09
More
About SVA
Sinovac Biotech Ltd (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, hand foot and mouth disease (HFMD), seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine.

Webull offers Sinovac Biotech Ltd stock information, including NASDAQ: SVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SVA stock methods without spending real money on the virtual paper trading platform.